Effect of Supplementing Medium Chain Triglycerides with Linoleic Acid-Rich Monoglycerides on Severely Disturbed Serum Lipid Fatty Acid Patterns in Patients with Cystic Fibrosis

1985 ◽  
Vol 29 (4) ◽  
pp. 239-245 ◽  
Author(s):  
A. Christophe ◽  
G. Verdonk ◽  
E. Robberecht ◽  
R. Mahathanakhun
Keyword(s):  
Cystic Fibrosis ◽  
Fatty Acid ◽  
Linoleic Acid ◽  
Serum Lipid ◽  
Medium Chain Triglycerides ◽  
Medium Chain ◽  
Lipid Fatty Acid ◽  
Fatty Acid Patterns

scholarly journals Functional Lipids as Nutraceuticals: A Review

2021 ◽  
Vol 6 (4) ◽  
pp. 111-123
Author(s):  
Sneha S. Bhat
Keyword(s):  
Fatty Acid ◽  
Linoleic Acid ◽  
Conjugated Linoleic Acid ◽  
Acid Medium ◽  
Scientific Data ◽  
Omega 3 ◽  
Medium Chain Triglycerides ◽  
Omega 3 Fatty Acid ◽  
Medium Chain ◽  
Omega 6

Stephen L. Defelice, founder and chairman of the Foundation of Innovation Medicine, created the term "Nutraceuticals" in 1989 as a combination of the words "nutrition" and "pharmaceutical." Nutraceuticals are food-derived products that are claimed to give additional health advantages in addition to the fundamental nutritional content present in meals. Their kinds may be more significant than their quantity in terms of health and disease. The aim of this review is to provide a summary of the research on the role of functional lipids namely: Omega -6 fatty acid, Omega -3 fatty acid, Conjugated linoleic acid, Medium chain triglycerides and Phytosterols as nutraceuticals in human health. Functional lipids have been related to the prevention and treatment of a variety of ailments, according to new study. With the use of supplementary and dietary forms of functional lipids, scientific data has demonstrated positive improvements in patients and favorable benefits in healthy people. Keywords: Nutraceuticals, Functional lipids, Conjugated linoleic acid, Medium chain triglycerides, Omega -6 fatty acid, Omega -3 fatty acid, Phytosterols,

Effect of medium-chain triglycerides on liver fatty acid composition in alcoholics with or without cirrhosis

1973 ◽  
Vol 26 (7) ◽  
pp. 738-743
Author(s):  
J. R. Malagelada ◽  
W. G. Linscheer ◽  
U. M. T. Houtsmuller ◽  
A. J. Vergroesen ◽  
M. Shah ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Liver Fatty Acid ◽  
Medium Chain Triglycerides ◽  
Medium Chain

scholarly journals Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day

2019 ◽  
Vol 6 ◽  
Author(s):  
Valérie St-Pierre ◽  
Camille Vandenberghe ◽  
Carolyne-Mary Lowry ◽  
Mélanie Fortier ◽  
Christian-Alexandre Castellano ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Chain Fatty Acid ◽  
Medium Chain Fatty Acid ◽  
Medium Chain Triglycerides ◽  
Metabolic Study ◽  
Medium Chain

scholarly journals Administration of an Intravenous Fat Emulsion Enriched with Medium-Chain Triglyceride/ω-3 Fatty Acids is Beneficial Towards Anti-Inflammatory Related Fatty Acid Profile in Preterm Neonates: A Randomized, Double-Blind Clinical Trial

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3526
Author(s):  
Panos Papandreou ◽  
Aristea Gioxari ◽  
Dimitrios Ntountaniotis ◽  
Olga-Natalia Korda ◽  
Maria Skouroliakou ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Linoleic Acid ◽  
Soybean Oil ◽  
Medium Chain Triglyceride ◽  
Preterm Neonates ◽  
Control Group ◽  
Fat Emulsion ◽  
Double Blind ◽  
Intravenous Fat Emulsion ◽  
Medium Chain

Intravenous administration of pure soybean oil emulsions high in linoleic acid may lead to inflammation and lipid peroxidation in preterm neonates. We aimed to investigate the effects of a medium-chain triglyceride (MCT)/ω-3 polyunsaturated fatty acid (PUFA)-enriched intravenous fat emulsion (IVFE) on plasma fatty acid (FA) profile and serum interleukin-6 (IL-6) in preterm neonates. In this double-blind randomized study, 92 preterm neonates (gestational age < 32 weeks, birth weight < 1500 g) were assigned to receive either MCT/ω-3 PUFA-enriched IVFE (Intervention Group) or soybean oil-based IVFE (Control Group). Levels of FAs were measured at baseline (day 0) and day 15 of parenteral nutrition with gas-chromatography mass-spectrometry. Serum IL-6 was measured with sandwich ELISA in 59 neonates. Plasma FAs changed significantly over time; the MCT/ω-3 PUFA-IVFE group showed higher ω-3 PUFAs (p = 0.031), eicosapentaenoic acid (p = 0.000), and oleic acid (p = 0.003), and lower ω-6/ω-3 PUFAs ratio (p = 0.001) and ω-6 PUFAs (p = 0.023) compared to control group. Linoleic acid was higher in the soybean oil (SO)-based IVFE arm compared to the MCT/ω-3 PUFAs-IVFE arm (p = 0.006). Both fat emulsion types decreased IL-6 compared to baseline, but changes were insignificant between groups. Administration of MCT/ω-3 PUFA-enriched IVFE in preterm neonates is beneficial in changing the FA profile consistent with attenuated inflammatory response.

scholarly journals Plasma fatty acids and [13C]linoleic acid metabolism in preterm infants fed a formula with medium-chain triglycerides

2002 ◽  
Vol 44 (1) ◽  
pp. 41-48 ◽  
Author(s):  
Maria Rodriguez ◽  
Simone Funke ◽  
Maria Fink ◽  
Hans Demmelmair ◽  
Marco Turini ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Linoleic Acid ◽  
Preterm Infants ◽  
Acid Metabolism ◽  
Medium Chain Triglycerides ◽  
Plasma Fatty Acids ◽  
Medium Chain ◽  
Linoleic Acid Metabolism
Sign in / Sign up

Export Citation Format

Share Document